| Richard Wade Oakden, MD | |
|
1059 N 100 W, Beaver, UT 84713-1690 | |
| (435) 438-7280 | |
| (435) 438-7210 |
| Full Name | Richard Wade Oakden |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 26 Years |
| Location | 1059 N 100 W, Beaver, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346245438 | NPI | - | NPPES |
| D4019 | Medicaid | UT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 48605621205 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Beaver Valley Home Health | Beaver, UT | Home health agency |
| Beaver Valley Hospital | Beaver, UT | Hospital |
| Cedar City Hospital | Cedar city, UT | Hospital |
| Garfield Memorial Hospital | Panguitch, UT | Hospital |
| Milford Memorial Hospital | Milford, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Beaver Medical, Llc | 2365352036 | 8 |
News Archive
TransPharma Medical Ltd., a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing a proprietary active transdermal drug delivery technology, announced today successful results of a Phase I clinical trial of its self-applied ViaDerm-Calcitonin product for the treatment of musculoskeletal disorders such as osteoarthritis and musculoskeletal pain.
Leftover prescription opioids pose big risks to kids, yet most parents keep their own and their child's unused painkillers even after they're no longer medically necessary for pain.
A new study from UK has found efficacy of psilocybin – a chemical found in "magic mushrooms", in severe depression. The study involved 19 patients with severe depression. The patients took the psilocybin and around half of them improved and reported maintained improvement after 5 weeks of therapy. The patients however also received psychological care along with the treatment.
Robbins Geller Rudman & Dowd LLP ("Robbins Geller") today announced that an amended class action complaint will be filed in the United States District Court for the Southern District of New York. The amended complaint will be on behalf of purchasers of Pfizer Inc. publicly traded securities during the period between January 19, 2006 and January 23, 2009.
Onyx Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted fast track designation for carfilzomib, a next generation proteasome inhibitor for the potential treatment of patients with relapsed and refractory multiple myeloma.
› Verified 7 days ago
| Entity Name | Beaver Valley Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144436429 PECOS PAC ID: 2769376326 Enrollment ID: O20040927000930 |
News Archive
TransPharma Medical Ltd., a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing a proprietary active transdermal drug delivery technology, announced today successful results of a Phase I clinical trial of its self-applied ViaDerm-Calcitonin product for the treatment of musculoskeletal disorders such as osteoarthritis and musculoskeletal pain.
Leftover prescription opioids pose big risks to kids, yet most parents keep their own and their child's unused painkillers even after they're no longer medically necessary for pain.
A new study from UK has found efficacy of psilocybin – a chemical found in "magic mushrooms", in severe depression. The study involved 19 patients with severe depression. The patients took the psilocybin and around half of them improved and reported maintained improvement after 5 weeks of therapy. The patients however also received psychological care along with the treatment.
Robbins Geller Rudman & Dowd LLP ("Robbins Geller") today announced that an amended class action complaint will be filed in the United States District Court for the Southern District of New York. The amended complaint will be on behalf of purchasers of Pfizer Inc. publicly traded securities during the period between January 19, 2006 and January 23, 2009.
Onyx Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted fast track designation for carfilzomib, a next generation proteasome inhibitor for the potential treatment of patients with relapsed and refractory multiple myeloma.
› Verified 7 days ago
| Entity Name | Beaver Medical, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770570202 PECOS PAC ID: 2365352036 Enrollment ID: O20050714000791 |
News Archive
TransPharma Medical Ltd., a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing a proprietary active transdermal drug delivery technology, announced today successful results of a Phase I clinical trial of its self-applied ViaDerm-Calcitonin product for the treatment of musculoskeletal disorders such as osteoarthritis and musculoskeletal pain.
Leftover prescription opioids pose big risks to kids, yet most parents keep their own and their child's unused painkillers even after they're no longer medically necessary for pain.
A new study from UK has found efficacy of psilocybin – a chemical found in "magic mushrooms", in severe depression. The study involved 19 patients with severe depression. The patients took the psilocybin and around half of them improved and reported maintained improvement after 5 weeks of therapy. The patients however also received psychological care along with the treatment.
Robbins Geller Rudman & Dowd LLP ("Robbins Geller") today announced that an amended class action complaint will be filed in the United States District Court for the Southern District of New York. The amended complaint will be on behalf of purchasers of Pfizer Inc. publicly traded securities during the period between January 19, 2006 and January 23, 2009.
Onyx Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted fast track designation for carfilzomib, a next generation proteasome inhibitor for the potential treatment of patients with relapsed and refractory multiple myeloma.
› Verified 7 days ago
| Entity Name | Beaver Valley Hospital |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1174979108 PECOS PAC ID: 2769376326 Enrollment ID: O20160525000523 |
News Archive
TransPharma Medical Ltd., a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing a proprietary active transdermal drug delivery technology, announced today successful results of a Phase I clinical trial of its self-applied ViaDerm-Calcitonin product for the treatment of musculoskeletal disorders such as osteoarthritis and musculoskeletal pain.
Leftover prescription opioids pose big risks to kids, yet most parents keep their own and their child's unused painkillers even after they're no longer medically necessary for pain.
A new study from UK has found efficacy of psilocybin – a chemical found in "magic mushrooms", in severe depression. The study involved 19 patients with severe depression. The patients took the psilocybin and around half of them improved and reported maintained improvement after 5 weeks of therapy. The patients however also received psychological care along with the treatment.
Robbins Geller Rudman & Dowd LLP ("Robbins Geller") today announced that an amended class action complaint will be filed in the United States District Court for the Southern District of New York. The amended complaint will be on behalf of purchasers of Pfizer Inc. publicly traded securities during the period between January 19, 2006 and January 23, 2009.
Onyx Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted fast track designation for carfilzomib, a next generation proteasome inhibitor for the potential treatment of patients with relapsed and refractory multiple myeloma.
› Verified 7 days ago
| Entity Name | Garfield County |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1508836867 PECOS PAC ID: 6305744459 Enrollment ID: O20161111001071 |
News Archive
TransPharma Medical Ltd., a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing a proprietary active transdermal drug delivery technology, announced today successful results of a Phase I clinical trial of its self-applied ViaDerm-Calcitonin product for the treatment of musculoskeletal disorders such as osteoarthritis and musculoskeletal pain.
Leftover prescription opioids pose big risks to kids, yet most parents keep their own and their child's unused painkillers even after they're no longer medically necessary for pain.
A new study from UK has found efficacy of psilocybin – a chemical found in "magic mushrooms", in severe depression. The study involved 19 patients with severe depression. The patients took the psilocybin and around half of them improved and reported maintained improvement after 5 weeks of therapy. The patients however also received psychological care along with the treatment.
Robbins Geller Rudman & Dowd LLP ("Robbins Geller") today announced that an amended class action complaint will be filed in the United States District Court for the Southern District of New York. The amended complaint will be on behalf of purchasers of Pfizer Inc. publicly traded securities during the period between January 19, 2006 and January 23, 2009.
Onyx Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted fast track designation for carfilzomib, a next generation proteasome inhibitor for the potential treatment of patients with relapsed and refractory multiple myeloma.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Richard Wade Oakden, MD Po Box 1690, Beaver, UT 84713-1690 Ph: (435) 438-7280 | Richard Wade Oakden, MD 1059 N 100 W, Beaver, UT 84713-1690 Ph: (435) 438-7280 |
News Archive
TransPharma Medical Ltd., a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing a proprietary active transdermal drug delivery technology, announced today successful results of a Phase I clinical trial of its self-applied ViaDerm-Calcitonin product for the treatment of musculoskeletal disorders such as osteoarthritis and musculoskeletal pain.
Leftover prescription opioids pose big risks to kids, yet most parents keep their own and their child's unused painkillers even after they're no longer medically necessary for pain.
A new study from UK has found efficacy of psilocybin – a chemical found in "magic mushrooms", in severe depression. The study involved 19 patients with severe depression. The patients took the psilocybin and around half of them improved and reported maintained improvement after 5 weeks of therapy. The patients however also received psychological care along with the treatment.
Robbins Geller Rudman & Dowd LLP ("Robbins Geller") today announced that an amended class action complaint will be filed in the United States District Court for the Southern District of New York. The amended complaint will be on behalf of purchasers of Pfizer Inc. publicly traded securities during the period between January 19, 2006 and January 23, 2009.
Onyx Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted fast track designation for carfilzomib, a next generation proteasome inhibitor for the potential treatment of patients with relapsed and refractory multiple myeloma.
› Verified 7 days ago
Roger Hal Smith, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1059 N 100 W, Beaver, UT 84713 Phone: 435-438-7280 Fax: 435-438-7210 | |
Dr. Lance Clyde Smith, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1059 N 100 W, Beaver, UT 84713 Phone: 435-438-7280 | |
Dr. Rhett R Smith, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1059 N 100 W, Beaver, UT 84713 Phone: 435-310-1660 | |
Bryon Noal Robinson, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1059 N 100 W, Beaver, UT 84713 Phone: 435-438-7280 Fax: 435-438-9721 | |
Dr. Zachary S Flinders, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1059 N 100 W, Beaver, UT 84713 Phone: 435-438-7280 Fax: 435-438-7210 |